Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CNMD

CNMD - CONMED Corp Stock Price, Fair Value and News

$38.68-0.90 (-2.27%)
Market Closed

54/100

CNMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

54/100

CNMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$43

Target 3M

$41.96

Target 6M

$42.3

CNMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CNMD Price Action

Last 7 days

-6.9%

Last 30 days

-6.7%

Last 90 days

-13.1%

Trailing 12 Months

-45.5%

CNMD RSI Chart

CNMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CNMD Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

18.7

Price/Sales (Trailing)

0.89

EV/EBITDA

14.86

Price/Free Cashflow

8.04

CNMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$43

Target 3M

$41.96

Target 6M

$42.3

CNMD Fundamentals

CNMD Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

6.7%

Rev. Growth (Qtr)

-1.29%

CNMD Earnings

Earnings (TTM)

64.1M

Earnings Growth (Yr)

-94.16%

Earnings Growth (Qtr)

-86.65%

CNMD Profitability

EBT Margin

6.35%

Return on Equity

6.35%

Return on Assets

2.76%

Free Cashflow Yield

12.44%

CNMD Investor Care

Dividend Yield

2.07%

Dividend/Share (TTM)

0.8

Shares Dilution (1Y)

0.25%

Diluted EPS (TTM)

2.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.3B1.3B1.3B0
20241.3B1.3B1.3B1.3B
20231.1B1.1B1.2B1.2B
20221.0B1.0B1.1B1.0B
2021881.1M978.5M989.5M1.0B
2020950.7M870.3M874.5M862.5M
2019875.9M901.4M932.7M955.1M
2018811.9M827.6M839.7M859.6M
2017768.9M772.6M777.9M796.4M
2016722.4M734.8M750.4M763.5M
2015736.1M728.9M723.2M719.2M
2014757.6M752.8M748.5M740.1M
2013759.8M763.1M760.5M762.7M
2012735.9M742.4M751.5M767.1M
2011720.8M723.0M723.6M725.1M
2010000713.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About CONMED Corp

CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
 CEO
 WEBSITEconmed.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES4100

CONMED Corp Frequently Asked Questions

CNMD is the stock ticker symbol of CONMED Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of CONMED Corp is 1.2 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CNMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether CNMD is over valued or under valued. Whether CONMED Corp is cheap or expensive depends on the assumptions which impact CONMED Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNMD.

As of Wed Jan 28 2026, CNMD's PE ratio (Price to Earnings) is 18.7 and Price to Sales (PS) ratio is 0.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, CONMED Corp has provided 0.005 (multiply by 100 for percentage) rate of return.